Jill A. Howe

Insider Reports History

Entity
Individual
Location
C/O Dtx Pharma, Inc., 10655 Sorrento Valley Road, Suite 100, San Diego, CA
Signature
/s/ Jill A. Howe
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jill A. Howe:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BIORA THERAPEUTICS, INC. Director Common Stock 31.9K $61K $3.14 Jun 5, 2024 Direct
Lineage Cell Therapeutics, Inc. Chief Financial Officer Common Shares 25.5K $15K $0.59 Nov 26, 2024 Direct
Lineage Cell Therapeutics, Inc. Chief Financial Officer Employee Stock Option (Right to Buy) 650K Mar 7, 2024 Direct
BIORA THERAPEUTICS, INC. Director Stock Option (Right to Buy) 12.5K Jun 5, 2024 Direct

Insider Reports Filed by Jill A. Howe

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LCTX Lineage Cell Therapeutics, Inc. Nov 26, 2024 1 $8.85K 4 Nov 26, 2024 Chief Financial Officer
LCTX Lineage Cell Therapeutics, Inc. Aug 16, 2024 1 $9.35K 4 Aug 19, 2024 Chief Financial Officer
BIOR BIORA THERAPEUTICS, INC. Jun 5, 2024 2 $0 4 Jun 6, 2024 Director
LCTX Lineage Cell Therapeutics, Inc. Mar 7, 2024 1 $0 4 Mar 8, 2024 Chief Financial Officer
BIOR BIORA THERAPEUTICS, INC. Jun 14, 2023 2 $0 4 Jun 16, 2023 Director
LCTX Lineage Cell Therapeutics, Inc. Mar 9, 2023 1 $0 4 Mar 10, 2023 Chief Financial Officer
BIOR BIORA THERAPEUTICS, INC. Jan 3, 2023 1 $0 4 Jan 5, 2023 Director
LCTX Lineage Cell Therapeutics, Inc. Nov 14, 2022 1 $0 4 Nov 16, 2022 Chief Financial Officer
LCTX Lineage Cell Therapeutics, Inc. Nov 14, 2022 0 $0 3 Nov 16, 2022 Chief Financial Officer
BIOR BIORA THERAPEUTICS, INC. Jun 15, 2022 2 $0 4 Jun 17, 2022 Director
BIOR PROGENITY, INC. Nov 3, 2021 2 $0 4 Nov 5, 2021 Director
BIOR PROGENITY, INC. Nov 3, 2021 0 $0 3 Nov 5, 2021 Director